B. Riley's Take On Cinemark, Imax, Marcus, National CineMedia, AMC Post 'Spider-Man: No Way Home'

"Spider-Man: No Way Home," a film released in the middle of an omicron variant surge with a multitude of at-home viewing platforms in focus, just generated the third-best domestic opening weekend box office of all time, B. Riley analyst Eric Wold noted.
"Those who are bearish on the potential for a post-pandemic exhibition industry recovery need to take notice of what just happened."
Related Content: 'Spider-Man: No Way Home' Rocks The US Box Office With $253M Opening
Wold added that with exclusive theatrical windows "proving their importance to the industry," the exhibitor group faces an " extremely attractive set-up heading into next year's slate."
He reiterated Buy on Cinemark Holdings Inc CNK, Imax Corp IMAX, Marcus Corp MCS, National CineMedia Inc NCMI.
Wold has a Neutral on AMC Entertainment Holdings Inc AMC.
Price Action: CNK shares traded higher by 0.31% at $16.26, while IMAX shares traded lower by 3.59% at $17.20 on Monday's last check.

Analyst Calendar